---
title: "Cryoport hits 52-week high"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305050691.md"
description: "Cryoport rose 0.54% to US$20.58. Up 51.18% over six months and up 114.17% YTD."
datetime: "2026-11-10T17:42:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305050691.md)
  - [en](https://longbridge.com/en/news/305050691.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305050691.md)
generator: "portal-rs"
---

# Cryoport hits 52-week high

Cryoport (CYRX.US) rose less than **1%** during regular trading to **$20.58**, hitting a 52-week high.

The stock is up 24.98% over the past five sessions, up 51.18% over the past six months and up 114.17% year to date. It sits 170.43% above its 52-week low of US$7.610.

The Nasdaq Composite is down 2.12% over the past five sessions and up 6.85% year to date.

Third-quarter revenue increased 14% from a year earlier to $50.2 million, topping analyst expectations. Adjusted EBITDA turned positive at $1.1 million, while net loss widened 56% from a year earlier to $10.85 million. Cryoport lifted its full-year 2026 revenue forecast to $197 million to $199 million, and its Paris facility received ISO certification.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [CYRX.US](https://longbridge.com/en/quote/CYRX.US.md)

## Related News & Research

- [CryoPort (NASDAQ:CYRX) Stock: Insider Daniel Hancock Sells 74,379 Shares](https://longbridge.com/en/news/305449778.md)
- [Cryoport (CYRX) Lifts 2026 Outlook Following Revenue Update As Fair Value Stays Just Behind](https://longbridge.com/en/news/304925527.md)
- [Keybanc maintains CryoPort at Overweight, raises price target to $20 from $17](https://longbridge.com/en/news/304652048.md)
- [AI solves 167-year-old maths problem, Anthropic researcher claims](https://longbridge.com/en/news/306318851.md)
- [GIGABYTE Concludes AI Partner Summit, Showcasing Real-World AI Agent Solutions for Enterprise](https://longbridge.com/en/news/306311368.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**